mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.8 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.8 |